Who owns the MAGNETODRONE trademark?

The MAGNETODRONE trademark is owned by Starpax Biopharma inc..

What is the serial number for MAGNETODRONE?

The USPTO serial number for MAGNETODRONE is 79359950.

What is the registration number for MAGNETODRONE?

MAGNETODRONE is registered under USPTO registration number 7341771.

MAG

USPTO Trademark Record

REGISTERED

MAGNETODRONE

Q: What class is the MAGNETODRONE trademark registered in?

The MAGNETODRONE trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

SN 79359950·Reg 7341771·Filed Dec 06, 2022

Owner Starpax Biopharma inc.

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

MAGNETODRONE (Serial No. 79359950), Registration No. 7341771, is a registered US trademark filed on Dec 06, 2022 by Starpax Biopharma inc.. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 044 (Medical, veterinary & beauty care services).

early section 8: April 02, 2030

Mark Intelligence

MAGNETODRONE (Reg. #7341771) is a registered US trademark that has been protecting its owner, Starpax Biopharma inc., since 2022. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 044 (Medical, veterinary & beauty care services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 3 opposition proceedings during prosecution.

FILED

Dec 06, 2022

SERIAL

79359950

REG#

7341771

REGISTERED

Apr 02, 2024

Owner

Applicant

Starpax Biopharma inc.

Entity

Corporation

Address

6615 Rue Abrams, Saint-Laurent H4S 1X9

Country

Attorney

NameMichelle P. Ciotola

Law firm

Michelle P. Ciotola Cantor Colburn LLP

Docket

COF0013TUS

Address

20 Church Street, 22nd Floor, Hartford, CT 06103, UNITED STATES

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateDec 06, 2022

Serial Number79359950

Registration No.7341771

Registration DateApr 02, 2024

Status DateApr 02, 2024

Published for OppositionJan 16, 2024

Mark TypeStandard characters

Attorney DocketCOF0013TUS

Status DescriptionLive and registered

Filing Signals

FILED

2022

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 3× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 044Medical, veterinary & beauty care services

US codes: 100, 101

Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, aquaculture, horticulture and forestry services.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

26 events

FINAL DECISION TRANSACTION PROCESSED BY IB

Nov 09, 2024

FINAL DECISION TRANSACTION PROCESSED BY IB

NEW REPRESENTATIVE AT IB RECEIVED

Oct 18, 2024

NEW REPRESENTATIVE AT IB RECEIVED

FINAL DISPOSITION PROCESSED

Oct 17, 2024

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Oct 17, 2024

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Jul 03, 2024

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Apr 02, 2024

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Apr 02, 2024

NOTICE OF REGISTRATION CONFIRMATION EMAILED

PUBLISHED FOR OPPOSITION

Jan 16, 2024

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 16, 2024

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

NOTIFICATION PROCESSED BY IB

Jan 13, 2024

NOTIFICATION PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 27, 2023

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

Dec 27, 2023

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Dec 27, 2023

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 13, 2023

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 29, 2023

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 29, 2023

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 29, 2023

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Oct 24, 2023

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Oct 02, 2023

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Oct 02, 2023

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Sep 21, 2023

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

NON-FINAL ACTION WRITTEN

Sep 20, 2023

NON-FINAL ACTION WRITTEN

ASSIGNED TO EXAMINER

Sep 13, 2023

ASSIGNED TO EXAMINER

APPLICATION FILING RECEIPT MAILED

Jan 13, 2023

APPLICATION FILING RECEIPT MAILED

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Jan 09, 2023

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Jan 06, 2023

SN ASSIGNED FOR SECT 66A APPL FROM IB

MAGNETODRONE

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Starpax Biopharma inc.

Other Marks by Michelle P. Ciotola

Resources

Company